Yixin Xu | Cardiovascular Researches | Best Researcher Award 2025

Dr. Yixin Xu | Cardiovascular Researches | Best Researcher Award

The First Affiliated Hospital of Army Medical University | China

Author Profile

Orcid

Early Academic Pursuits

YiXin Xu began her medical journey at Xinjiang Medical University, where she pursued an undergraduate degree in Clinical Medicine. Her strong academic performance and dedication to patient care inspired her to continue postgraduate studies in Internal Medicine, specializing in cardiovascular medicine. This early pursuit of advanced knowledge built the foundation for her growing expertise in both clinical practice and research.

Professional Endeavors

Her professional development included an internship at the Traditional Chinese Medicine Hospital of Shapingba District in Chongqing City, where she gained valuable clinical exposure. She then undertook standardized resident physician training at the First Affiliated Hospital of Xinjiang Medical University. During this period, she successfully managed patient care, independently handled on-duty responsibilities, and developed expertise in treating conditions such as coronary heart disease, hypertension, and pulmonary hypertension.

Contributions And Research Focus

She has contributed to several important research projects that bridge clinical practice with scientific inquiry. These include investigating the relationship between vitamin D, parathyroid hormone, and circadian rhythms in blood pressure regulation among patients with hypertension. She also participated in the Step-Pre Project and the "iCare-Me" initiative, both of which aim to improve patient outcomes through innovative approaches. Additionally, she contributed to the creation of a predictive model for heart failure in patients with coronary heart disease, based on metabolic biomarkers, highlighting her focus on precision medicine and translational research.

Clinical Expertise

Through her training, she became proficient in both the theoretical and practical aspects of internal medicine. She is skilled in the standardized documentation of medical records, surgical notes, and disease course records. Her technical expertise includes performing essential clinical procedures such as abdominal puncture and bone marrow puncture. These abilities underscore her readiness to practice medicine at a high professional standard.

Impact And Influence

Her dual contributions as a clinician and researcher have positioned her to influence both patient care and the scientific community. By combining clinical experience with data-driven research, she advances understanding in cardiovascular disease while improving strategies for patient management. Her work reflects a commitment to bridging the gap between medical research and real-world healthcare delivery.

Academic Cites

Her scholarly contributions have been acknowledged through participation in collaborative studies and cited within ongoing cardiovascular research initiatives. These academic references reflect her growing influence and recognition within the medical research community.

Legacy And Future Contributions

Looking forward, she aspires to strengthen predictive models for cardiovascular disease and enhance evidence-based treatment protocols. Her career vision includes contributing to global medical research networks, publishing impactful studies, and advancing patient care practices through innovation and collaboration.

Conclusion

YiXin Xu exemplifies the qualities of a dedicated physician and researcher. With her academic excellence, clinical expertise, and meaningful research contributions, she is poised to make significant advancements in cardiovascular medicine. Her commitment to innovation and patient-centered care ensures that she will leave a lasting impact on both clinical practice and medical science.

Notable Publication

"Parathyroid hormone and vitamin D modulate nocturnal blood pressure dipping: a retrospective cohort study in primary hypertension"

Authors: Yixin Xu, Changjiang Deng, Xiaohui Liang
Journal: Clinical and Experimental Hypertension
Year: 2025

Jian-Jun Li | Cardiology | Best Researcher Award

Prof. Dr. Jian-Jun Li | Cardiology | Best Researcher Award

Prof. Dr. Jian-Jun Li, Fuwai hospital, China

Prof. Dr. Jian-Jun Li is a renowned cardiologist at Fu Wai Hospital, Chinese Academy of Medical Science, Beijing. He holds an MD from Wuhan University, a PhD from Kyushu University, Japan, and completed post-doctoral training in the USA. As Professor and Consultant at the Cardiometabolic Center, his research focuses on dyslipidemia, inflammation, atherosclerosis, and interventional cardiology. He serves as Vice President of the Chinese Molecular College of Cardiology and is a national expert in cardiovascular disease prevention. Prof. Li has received multiple prestigious science awards, recognizing his significant contributions to cardiovascular medicine and public health in China.

AUTHOR PROFILE

Scopus Profile

👨‍🎓 EARLY ACADEMIC PURSUITS:

Prof. Dr. Jian-Jun Li began his academic journey in medicine at Wuhan University, China, where he pursued his MD from 1978 to 1986. With a strong foundation in clinical and theoretical medical sciences, he furthered his education with a PhD from Kyushu University, Japan (1991–1995)—a prestigious institution known for its cutting-edge biomedical research. He then expanded his international experience through a Post-doctoral Fellowship at the University of Louisville, USA (1995–1997), where he explored advanced cardiovascular research.

👨‍⚕️ PROFESSIONAL ENDEAVORS:

Currently, Prof. Dr. Jian-Jun Li serves as a Professor and Consultant at the Cardiometabolic Center, Fu Wai Hospital, affiliated with the Chinese Academy of Medical Science and Peking Union Medical College, Beijing. This esteemed role places him at the heart of China’s most influential medical and research institution for cardiovascular health.

In addition to his primary role:

  •  He is the Vice President of the Chinese Molecular College of Cardiology.

  •  He is a Member of the National Expert Committee on Prevention and Control of Cardiovascular Disease.

  •  He is an Expert Member of the Chinese Doctor Union.

đź§Ş CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOLOGY:

Prof. Dr. Jian-Jun Li’s research work is both broad and impactful, focusing on some of the most critical issues in modern cardiology:

  • Dyslipidemia – studying abnormal lipid levels and their role in cardiovascular disease.

  • Inflammation and Atherosclerosis – understanding how chronic inflammation contributes to plaque buildup in arteries.

  • Interventional Cardiology – innovating and improving minimally invasive procedures to treat cardiovascular conditions.

His work bridges the gap between molecular cardiology and clinical applications, aiming for preventive and therapeutic breakthroughs in cardiovascular health.

🏆 IMPACT AND INFLUENCE:

Prof. Li’s contributions have been nationally and internationally acknowledged:

  • Secondary Awards of National Science and Technology in Advance (2002)

  • Hubei Province Awards of Chinese Science and Technology in Advance for five consecutive years: 1999–2003

These awards reflect the consistency, excellence, and innovation in his work, particularly in translational medicine and cardiovascular disease control.

📚 ACADEMIC CITES AND COLLABORATIONS:

Prof. Li has been widely cited in national and international scientific publications. His peer-reviewed research articles in leading cardiology and internal medicine journals have significantly influenced clinical practices in China and abroad. His collaborations with researchers in Japan, the USA, and Europe have expanded the global reach of Chinese cardiovascular research.

🧬 LEGACY AND FUTURE CONTRIBUTIONS:

As a visionary academic and physician, Prof. Li’s legacy is cemented in:

  •  Mentoring the next generation of cardiologists and researchers in China.

  •  Shaping policy frameworks for cardiovascular disease prevention nationwide.

  •  Advancing personalized medicine approaches in dyslipidemia and atherosclerosis.

  •  Promoting international cooperation in cardiovascular research.

His future contributions are likely to continue influencing both clinical and molecular cardiology, especially in integrative therapeutic techniques and public health strategies.

🌟CONCLUSION:

Prof. Dr. Jian-Jun Li stands as a leading figure in the field of cardiology, combining clinical expertise with groundbreaking research. His contributions to understanding and treating dyslipidemia, inflammation, and atherosclerosis have advanced both preventive and interventional cardiology in China and beyond. Through his leadership roles and active participation in national health committees, he continues to influence cardiovascular disease prevention strategies. His dedication to medical science, mentorship, and innovation ensures a lasting legacy in improving heart health. Prof. Li’s work not only enhances clinical outcomes but also inspires the next generation of medical researchers and practitioners.

TOP NOTABLE PUBLICATIONS

Article: Association of Insomnia, Lipid Profile, and Lipid-Lowering Medications: A Narrative Review

Authors: Jia, Fang; Shi, Shunyi; Fei, Sifan; Zhou, Min; Li, Jianjun

Journal: Review

Article: Moderate-Intensity Statin Plus Ezetimibe: Time to Rethink it as an Optimal Initial Lipid-Lowering Strategy

Authors: Li, Sha; Liu, Huihui; Li, Jianjun

Journal: Review

Article: Tafolecimab, a Third Monoclonal Antibody for PCSK9 as the Novel Lipid-Lowering Drug Around the World: A Narrative Review

Authors: Liu, Huihui; Li, Sha; Li, Jianjun

Journal: Review

Article: The effect of lipid-lowering therapy on lipid-related residual risk factors: a prospective study

Authors: Li, Zhifan; Gao, Yanan; Lu, Qianhong; Qiu, Hong; Wu, Naqiong; Li, Jianjun

Journal: Lipids in Health and Disease

Year: 2024

Article: The Effects of Sacubitril/Valsartan Compared to Olmesartan on the Blood Pressure and Glucolipid Metabolism in DM Patients with Primary Hypertension

Authors: Zhang, Shuang; Yin, Zheng; Li, Zhifan; Qian, Jie; Wu, Naqiong; Li, Jianjun

Journal: Cardiovascular Drugs and Therapy

Year: 2024

Article: Twin Phenomena of Hypertrophic Cardiomyopathy: A Reported Case Series

Authors: Zeng, Jiangting; Zhang, Ying’ai; Ma, Tianyi; Zhong, Jianghua; Li, Jianjun

Journal: Review

Article: Prognostic role of lipoprotein(a) in atherosclerotic cardiovascular disease risk from a perspective on current risk stratification

Authors: Li, Sha; Liu, Huihui; Zhang, Yan; Guo, Yuanlin; Li, Jianjun

Journal: MedComm

Year: 2024

Editorial: Lipids, Genetics, and the Risk of Type 2 Diabetes: More Studies Needed to Uncover the Mysteries

Author: Li, Jianjun

Journal: Editorial

Article: Prognostic value of red blood cell distribution width-to-albumin ratio in patients with stable coronary artery disease stratified by glucose metabolic status: a prospective cohort study

Authors: Liu, Huihui; Guo, Yuanlin; Zhu, Chenggang; Qian, Jie; Li, Jianjun

Journal: Cardiology Plus

Year: 2024

Article: Lipoprotein(a) and ischemic stroke: current insights and knowledge gaps

Authors: Yang, Cheng; Wu, Yongjian; Qian, Jie; Li, Jianjun

Journal: Review